Physician

Apur Ramesh Kamdar, M.D.

According to 2025 Medicare claims, Apur Kamdar, M.D. (NPI: 1902844863) practices interventional cardiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Rowan, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1679295398; TIN: 581728803) and primary practice location at 28144-2735. Kamdar is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Kamdar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,124 traditional Medicare patients, billed 2,980 HCPCS/CPT codes, and received $124,900 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,421 prescription claims across 684 beneficiaries totaling $727,029 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 12 claims. Open Payments data shows 6 records totaling $172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $267,803 to $727,029. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,313	3,363	$188,621
2016	1,543	3,651	$180,517
2017	1,500	3,556	$174,168
2018	1,483	3,171	$164,166
2019	1,481	3,430	$163,827
2020	1,344	3,014	$145,064
2021	1,462	3,596	$158,978
2022	1,304	2,946	$129,512
2023	1,280	3,182	$143,379
2024	1,124	2,980	$124,900

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	361	3,465	$267,803
2016	375	3,717	$339,491
2017	404	3,557	$396,633
2018	420	3,688	$385,147
2019	458	3,551	$431,639
2020	481	3,901	$542,355
2021	524	3,800	$582,264
2022	566	4,238	$748,164
2023	641	4,313	$832,887
2024	684	4,421	$727,029

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$668
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	318	402	$89
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	305	307	$82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	178	186	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	259	270	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	502	897	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	340	14,956	$290,329
Repatha Sureclick	Evolocumab	232	8,792	$172,779
Entresto	Sacubitril/Valsartan	103	4,178	$91,853
Praluent Pen	Alirocumab	52	1,960	$33,453
Xarelto	Rivaroxaban	16	1,460	$28,086

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$172	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Apur Ramesh Kamdar, M.D.?

Tedicare shows public-source Medicare data for Apur Ramesh Kamdar, M.D. (NPI 1902844863), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Apur Ramesh Kamdar, M.D. have ACO affiliation data?

Apur Ramesh Kamdar, M.D. is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Apur Ramesh Kamdar, M.D.?

Apur Ramesh Kamdar, M.D. is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1679295398) in the available physician profile data.

Does Apur Ramesh Kamdar, M.D. have Open Payments data?

Apur Ramesh Kamdar, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.